Role of molecular charge in disruption of the blood-brain barrier during acute hypertension

W. G. Mayhan, F. M. Faraci, J. L. Siems, D. D. Heistad

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Acute hypertension disrupts the blood-brain barrier and may neutralize the negative charge on cerebral endothelium. The goal of this study was to determine the effects of molecular charge on permeability of the blood-brain barrier during acute hypertension. Intravital fluorescent microscopy and fluorescein-labeled dextrans were used to evaluate disruption of the blood-brain barrier during acute hypertension in rats. Disruption of the blood-brain barrier was quantitated by calculating clearance of neutral dextran and of anionic dextran sulfate in two groups of rats. Pressure in pial venules, which are the primary site of disruption of the blood-brain barrier during acute hypertension, was measured using a servo-null device. When systemic arterial pressure was increased from 87 ± 5 (mean ± SEM) to 188 ± 5 mm Hg, clearance of neutral dextran increased from 0.04 ± 0.01 to 4.38 ± 0.72 ml/sec x 10-6. When systemic arterial pressure was increased from 91 ± 4 to 181 ± 3 mm Hg, clearance of anionic dextran sulfate increased from 0.02 ± 0.01 to only 0.70 to 0.23 ml/sec x 10-6. Increases in pial venular pressure were similar in the two groups. Thus, similar increases in systemic arterial pressure and pial venular pressure during acute hypertension produce less disruption of the blood-brain barrier to anionic dextran sulfate than neutral dextran. The findings suggest that 1) the net negative charge of cerebral vessels may be preserved during acute hypertension, and 2) molecular charge is an important determinant of the severity of disruption of the blood-brain barrier during acute hypertension.

Original languageEnglish (US)
Pages (from-to)658-664
Number of pages7
JournalCirculation Research
Volume64
Issue number4
DOIs
StatePublished - Jan 1 1989

Fingerprint

Blood-Brain Barrier
Hypertension
Dextran Sulfate
Dextrans
Arterial Pressure
Pressure
Venules
Endothelium
Permeability
Equipment and Supplies

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Role of molecular charge in disruption of the blood-brain barrier during acute hypertension. / Mayhan, W. G.; Faraci, F. M.; Siems, J. L.; Heistad, D. D.

In: Circulation Research, Vol. 64, No. 4, 01.01.1989, p. 658-664.

Research output: Contribution to journalArticle

Mayhan, W. G. ; Faraci, F. M. ; Siems, J. L. ; Heistad, D. D. / Role of molecular charge in disruption of the blood-brain barrier during acute hypertension. In: Circulation Research. 1989 ; Vol. 64, No. 4. pp. 658-664.
@article{19b3a0d7679743b182a245e282f4048d,
title = "Role of molecular charge in disruption of the blood-brain barrier during acute hypertension",
abstract = "Acute hypertension disrupts the blood-brain barrier and may neutralize the negative charge on cerebral endothelium. The goal of this study was to determine the effects of molecular charge on permeability of the blood-brain barrier during acute hypertension. Intravital fluorescent microscopy and fluorescein-labeled dextrans were used to evaluate disruption of the blood-brain barrier during acute hypertension in rats. Disruption of the blood-brain barrier was quantitated by calculating clearance of neutral dextran and of anionic dextran sulfate in two groups of rats. Pressure in pial venules, which are the primary site of disruption of the blood-brain barrier during acute hypertension, was measured using a servo-null device. When systemic arterial pressure was increased from 87 ± 5 (mean ± SEM) to 188 ± 5 mm Hg, clearance of neutral dextran increased from 0.04 ± 0.01 to 4.38 ± 0.72 ml/sec x 10-6. When systemic arterial pressure was increased from 91 ± 4 to 181 ± 3 mm Hg, clearance of anionic dextran sulfate increased from 0.02 ± 0.01 to only 0.70 to 0.23 ml/sec x 10-6. Increases in pial venular pressure were similar in the two groups. Thus, similar increases in systemic arterial pressure and pial venular pressure during acute hypertension produce less disruption of the blood-brain barrier to anionic dextran sulfate than neutral dextran. The findings suggest that 1) the net negative charge of cerebral vessels may be preserved during acute hypertension, and 2) molecular charge is an important determinant of the severity of disruption of the blood-brain barrier during acute hypertension.",
author = "Mayhan, {W. G.} and Faraci, {F. M.} and Siems, {J. L.} and Heistad, {D. D.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1161/01.RES.64.4.658",
language = "English (US)",
volume = "64",
pages = "658--664",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Role of molecular charge in disruption of the blood-brain barrier during acute hypertension

AU - Mayhan, W. G.

AU - Faraci, F. M.

AU - Siems, J. L.

AU - Heistad, D. D.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Acute hypertension disrupts the blood-brain barrier and may neutralize the negative charge on cerebral endothelium. The goal of this study was to determine the effects of molecular charge on permeability of the blood-brain barrier during acute hypertension. Intravital fluorescent microscopy and fluorescein-labeled dextrans were used to evaluate disruption of the blood-brain barrier during acute hypertension in rats. Disruption of the blood-brain barrier was quantitated by calculating clearance of neutral dextran and of anionic dextran sulfate in two groups of rats. Pressure in pial venules, which are the primary site of disruption of the blood-brain barrier during acute hypertension, was measured using a servo-null device. When systemic arterial pressure was increased from 87 ± 5 (mean ± SEM) to 188 ± 5 mm Hg, clearance of neutral dextran increased from 0.04 ± 0.01 to 4.38 ± 0.72 ml/sec x 10-6. When systemic arterial pressure was increased from 91 ± 4 to 181 ± 3 mm Hg, clearance of anionic dextran sulfate increased from 0.02 ± 0.01 to only 0.70 to 0.23 ml/sec x 10-6. Increases in pial venular pressure were similar in the two groups. Thus, similar increases in systemic arterial pressure and pial venular pressure during acute hypertension produce less disruption of the blood-brain barrier to anionic dextran sulfate than neutral dextran. The findings suggest that 1) the net negative charge of cerebral vessels may be preserved during acute hypertension, and 2) molecular charge is an important determinant of the severity of disruption of the blood-brain barrier during acute hypertension.

AB - Acute hypertension disrupts the blood-brain barrier and may neutralize the negative charge on cerebral endothelium. The goal of this study was to determine the effects of molecular charge on permeability of the blood-brain barrier during acute hypertension. Intravital fluorescent microscopy and fluorescein-labeled dextrans were used to evaluate disruption of the blood-brain barrier during acute hypertension in rats. Disruption of the blood-brain barrier was quantitated by calculating clearance of neutral dextran and of anionic dextran sulfate in two groups of rats. Pressure in pial venules, which are the primary site of disruption of the blood-brain barrier during acute hypertension, was measured using a servo-null device. When systemic arterial pressure was increased from 87 ± 5 (mean ± SEM) to 188 ± 5 mm Hg, clearance of neutral dextran increased from 0.04 ± 0.01 to 4.38 ± 0.72 ml/sec x 10-6. When systemic arterial pressure was increased from 91 ± 4 to 181 ± 3 mm Hg, clearance of anionic dextran sulfate increased from 0.02 ± 0.01 to only 0.70 to 0.23 ml/sec x 10-6. Increases in pial venular pressure were similar in the two groups. Thus, similar increases in systemic arterial pressure and pial venular pressure during acute hypertension produce less disruption of the blood-brain barrier to anionic dextran sulfate than neutral dextran. The findings suggest that 1) the net negative charge of cerebral vessels may be preserved during acute hypertension, and 2) molecular charge is an important determinant of the severity of disruption of the blood-brain barrier during acute hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0024556302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024556302&partnerID=8YFLogxK

U2 - 10.1161/01.RES.64.4.658

DO - 10.1161/01.RES.64.4.658

M3 - Article

C2 - 2467761

AN - SCOPUS:0024556302

VL - 64

SP - 658

EP - 664

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 4

ER -